What is a stock summary page? Click here for an overview.
Business Description
Baijin Life Science Holdings Ltd
NAICS : 423940
SIC : 5094
ISIN : KYG0130B1014
Compare
Compare
Traded in other countries / regions
01466.Hong KongMNNGF.USA IPO Date
2015-02-19Description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.68 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.76 | |||||
| Debt-to-EBITDA | 154.98 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -21.9 | |||||
| 3-Year EBITDA Growth Rate | 62.1 | |||||
| 3-Year EPS without NRI Growth Rate | 65.1 | |||||
| 3-Year FCF Growth Rate | 46.4 | |||||
| 3-Year Book Growth Rate | -4.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 99.88 | |||||
| 9-Day RSI | 97.16 | |||||
| 14-Day RSI | 90.15 | |||||
| 6-1 Month Momentum % | -14.29 | |||||
| 12-1 Month Momentum % | -20 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.34 | |||||
| Cash Ratio | 0.6 | |||||
| Days Inventory | 229.55 | |||||
| Days Sales Outstanding | 59.4 | |||||
| Days Payable | 33.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -34.3 | |||||
| Shareholder Yield % | -19.44 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.44 | |||||
| Operating Margin % | -9.42 | |||||
| Net Margin % | -11.42 | |||||
| FCF Margin % | -14.93 | |||||
| ROE % | -13.2 | |||||
| ROA % | -6.41 | |||||
| ROIC % | -13 | |||||
| 3-Year ROIIC % | 39.19 | |||||
| ROC (Joel Greenblatt) % | -9.65 | |||||
| ROCE % | -3.53 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 38.46 | |||||
| PS Ratio | 3.38 | |||||
| PB Ratio | 3.91 | |||||
| EV-to-EBIT | -85.38 | |||||
| EV-to-EBITDA | 933.18 | |||||
| EV-to-Revenue | 3.98 | |||||
| EV-to-FCF | -26.64 | |||||
| Price-to-GF-Value | 3 | |||||
| Price-to-Projected-FCF | 6 | |||||
| Earnings Yield (Greenblatt) % | -1.17 | |||||
| FCF Yield % | -4.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MNNGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Baijin Life Science Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.75 | ||
| EPS (TTM) ($) | -0.002 | ||
| Beta | 15626.88 | ||
| 3-Year Sharpe Ratio | 0.63 | ||
| 3-Year Sortino Ratio | 5.49 | ||
| Volatility % | 38.92 | ||
| 14-Day RSI | 90.15 | ||
| 14-Day ATR ($) | 0.000112 | ||
| 20-Day SMA ($) | 0.06 | ||
| 12-1 Month Momentum % | -20 | ||
| 52-Week Range ($) | 0.04 - 0.075 | ||
| Shares Outstanding (Mil) | 707.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baijin Life Science Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baijin Life Science Holdings Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baijin Life Science Holdings Ltd Frequently Asked Questions
What is Baijin Life Science Holdings Ltd(MNNGF)'s stock price today?
The current price of MNNGF is $0.06. The 52 week high of MNNGF is $0.08 and 52 week low is $0.04.
When is next earnings date of Baijin Life Science Holdings Ltd(MNNGF)?
The next earnings date of Baijin Life Science Holdings Ltd(MNNGF) is 2025-06-20 Est..
Does Baijin Life Science Holdings Ltd(MNNGF) pay dividends? If so, how much?
Baijin Life Science Holdings Ltd(MNNGF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers